Correvio Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Correvio Pharma (CORV) Misses Q1 EPS by 3c, Revenues Miss
May 8, 2019 8:10 AM EDTCorrevio Pharma (NASDAQ: CORV) reported Q1 EPS of ($0.23), $0.03 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $7.3 million versus the consensus estimate of $7.89 million.
"2019 is off to a strong start with first quarter revenues up 16% year-over-year in local... More
